Ghisallo Capital Management »

Corvus Pharmaceuticals shares owned by Ghisallo Capital Management

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by Ghisallo Capital Management from 13F filings

Historical chart of Ghisallo Capital Management investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by Ghisallo Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by Ghisallo Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $146k 10k 14.63

More positions owned by Ghisallo Capital Management

Medline Com Cl A (MDLN)
Xpeng Ads (XPEV)
Hyuhi 05/04/31 Cvt Put Convertible Bond
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Ztoec 0.925 03/01/31 Cvt Put Convertible Bond
Microsoft Corporation (MSFT)
Wiwynn 04/01/31 Convertible Bond
Chpac 09/18/30 Cvt Put Convertible Bond
Globalfoundries Ordinary Shares (GFS)
Trane Technologies SHS (TT)
Johnson Controls Internation SHS (JCI)
Nipst 02/14/29 Cvt Convertible Bond
Oracle Corporation (ORCL)
Bltiv 02/05/33 Cvt Put Convertible Bond (JTGLF)

View all positions for Ghisallo Capital Management

Top funds holding Corvus Pharmaceuticals

OrbiMed Advisors
BlackRock
Vanguard Group
Adams Street Partners
Vanguard Capital Management
Vivo Capital
State Street Corporation
Morgan Stanley
Deep Track Capital
Perceptive Advisors
Commodore Capital
Foresite Capital Management VI
Braidwell
Geode Capital Management
MPM Oncology Impact Management

View all funds holding Corvus Pharmaceuticals